Friedman Zeev, Katznelson Rita, Phillips Shannon R, Zanchetta Cristina, Nistor Oana-Irina, Eisen Leonard B, Siddiqui Naveed
Department of Anesthesia, Mount Sinai Hospital, University of Toronto, Toronto, Ontariom, Canada.
Pain Pract. 2008 Jul-Aug;8(4):248-52. doi: 10.1111/j.1533-2500.2008.00212.x. Epub 2008 May 23.
An ideal patient-controlled analgesia (PCA) opioid would have both a rapid onset and a long duration of action, attributes, which are not available in currently existing opioids including morphine, the most widely used agent. A mixture of rapid onset and long-acting opioids may potentially achieve both these qualities. In a randomized, double-blind study, we compared a fentanyl-morphine combination with morphine alone for PCA, in 54 patients undergoing bowel surgery. The combination solution was prepared according to a 1:75 fentanyl to morphine potency ratio. The mixture contained fentanyl 13.33 mug/mL and morphine 1 mg/mL. The morphine alone solution contained 2 mg/mL. Patients were randomly allocated to one of the regimens and were then evaluated 4 times during the first 48 hours following surgery. Time to effect, visual analog pain scores, opioid consumption, demands, deliveries, and side effects on an opioid-related symptom distress scale were recorded. Groups were well matched for age, weight, and sex. There were no significant differences between groups in time to effect, PCA usage, pain scores or side effects other than the occurrence of nausea, which was lower for the combination group in 1 visit. Further studies are needed to explore the potential of different potency ratios and opioid combinations to achieve rapid and long-lasting pain control.
理想的患者自控镇痛(PCA)阿片类药物应具有起效迅速和作用时间长的特点,而目前包括最广泛使用的吗啡在内的现有阿片类药物都不具备这些特性。速效和长效阿片类药物的混合物可能会兼具这两种特性。在一项随机双盲研究中,我们将芬太尼 - 吗啡组合与单独使用吗啡用于PCA的效果进行了比较,研究对象为54例接受肠道手术的患者。组合溶液按照芬太尼与吗啡效价比1:75配制。该混合物含有13.33μg/mL的芬太尼和1mg/mL的吗啡。单独使用吗啡的溶液含有2mg/mL。患者被随机分配至其中一种治疗方案,然后在术后的头48小时内进行4次评估。记录起效时间、视觉模拟疼痛评分、阿片类药物消耗量、需求次数、给药次数以及阿片类药物相关症状困扰量表上的副作用。两组在年龄、体重和性别方面匹配良好。除了在一次访视中联合组恶心发生率较低外,两组在起效时间、PCA使用情况、疼痛评分或副作用方面均无显著差异。需要进一步研究来探索不同效价比和阿片类药物组合实现快速持久疼痛控制的潜力。